Cesar de la Fuente
University of Pennsylvania
Biography
C茅sar de la Fuente is a Presidential Assistant Professor at the University of Pennsylvania, where he leads the Machine Biology Group whose goal is to combine the power of machines and biology to help prevent, detect, and treat infectious diseases. Specifically, he pioneered the development of the first antibiotic designed by the computer with efficacy in animals, designed algorithms for antibiotic discovery, reprogrammed venoms into antimicrobials, created novel resistance-proof antimicrobial materials, and invented rapid low-cost diagnostics for COVID-19 and other infections. De la Fuente is an NIH MIRA investigator and has received recognition and research funding from numerous other groups. Prof. de la Fuente has received over 50 awards. He was recognized by MIT Technology Review as one of the world鈥檚 top innovators for 鈥渄igitizing evolution to make better antibiotics鈥�. He was selected as the inaugural recipient of the Langer Prize, an ACS Kavli Emerging Leader in 九州影院, and received the AIChE鈥檚 35 Under 35 Award and the ACS Infectious Diseases Young Investigator Award. In 2021, he received the Thermo Fisher Award, and the EMBS Academic Early Career Achievement Award 鈥淔or the pioneering development of novel antibiotics designed using principles from computation, engineering, and biology.鈥� Most recently, Prof. de la Fuente was awarded the prestigious Princess of Girona Prize for Scientific Research, the ASM Award for Early Career Applied and Biotechnological Research and has been named a Highly Cited Researcher by Clarivate several times. Prof. de la Fuente has given over 200 invited lectures and his scientific discoveries have yielded over 110 publications, including papers in Nature Biomedical Engineering, Nature Communications, PNAS, ACS Nano, Cell, Nature Chemical Biology, Advanced Materials, and multiple patents.
RSC affiliations
Editorial board, Digital Discovery